• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: VASCUTEK LTD. GELWEAVE; GELWEAVE STRAIGHT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

VASCUTEK LTD. GELWEAVE; GELWEAVE STRAIGHT Back to Search Results
Model Number GELWEAVE STRAIGHT
Device Problem Insufficient Information (3190)
Patient Problems Insufficient Information (4580); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 01/18/2024
Event Type  Death  
Manufacturer Narrative
Manufacturer narrative: clinical code: 4582 - health effect - no clinical sign's, symptoms or conditions , no clinical sequelae impact code: 4632 - prolonged surgery - the 8mm graft that was used was removed and replaced with a 10 mm graft medical device problem: 3190 - insufficient information- reported as leakage component code: 4755 - part/component/sub-assembly term not applicable type of investigation: 4110 - trend analysis: a 5-year review of similar complaints (leakage > other (b)(60 v gelweave sales (b)(6) gave an occurrence rate of (b)(4).4111 - communication interview: additional information from has been requested from the site.3331 - analysis of production records: full batch review performed which showed no issues with the device during manufacture from raw material to finished products 10 - testing of actual device, device is being returned for analysis.
 
Event Description
Graft was leaking blood during procedure.Physician stated it was not handling blood the way it normally would.
 
Manufacturer Narrative
Manufacturer narrative: clinical code: 4582 - health effect - no clinical sign's, symptoms or conditions , no clinical sequelae.Impact code: 4632 - prolonged surgery - the 8mm graft that was used was removed and replaced with a 10 mm graft.Medical device problem: 3190 - insufficient information- reported as leakage.Component code: 4755 - part/component/sub-assembly term not applicable.Type of investigation: 4110 - trend analysis: a 5-year review of similar complaints (leakage > other jan 19 - jan 24 v gelweave sales jan 19 - jan 24 ) gave an occurrence rate of (b)(4).4111 - communication interview: additional information from has been requested from the site.3331 - analysis of production records: full batch review performed which showed no issues with the device during manufacture from raw material to finished products.10 - testing of actual device, device is being returned for analysis.Investigation findings: 213 - no device problem found - analysis of the returned graft was performed on 07 mar 24 , no issues could be found with the device on further investigation.The returned section of graft was heavily contaminated with blood.From the images supplied by the surgeon the blood leakage looks like it is at the distal end of the graft from the cannula and that the proximal end was blood tight (see image 1 above).The textile analysis shows that the physical characteristics of the base fabric of the graft were within specification which rules out the base fabric as being the root cause of this failure.The other potential root cause is inadequate coverage of gelatin along the length of the graft, unfortunately we could not carry out gelatin analysis because of the presence of large amounts of blood on the graft.However, all gelatin sealed grafts undergo leakage testing during manufacture.This graft passed this test which confirms that the gelatin coverage was sufficient to prevent excessive leakage from the full length of the graft during this test.Investigation conclusion: 67 - no problem detected - as this graft was replaced and the leakage was on going the root cause was deemed to be not device related.Additional information : section h1 - additional information was received to say patient passed away, cause was family withdrawal of care due to prolonged care without meaningful recovery, he was 83.Indirectly bleeding from the graft did prolong the care and significantly change the course.
 
Event Description
Graft was leaking blood during procedure.Physician stated it was not handling blood the way it normally would.This report is being submitted as follow up #1 to provide event closure information for mfg report#: 9162515-2024-00007 (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GELWEAVE
Type of Device
GELWEAVE STRAIGHT
Manufacturer (Section D)
VASCUTEK LTD.
newmains avenue
inchinnan business park
glasgow, renfrewshire PA4 9 RR
UK  PA4 9RR
Manufacturer (Section G)
VASCUTEK LTD.
newmains avenue
inchinnan business park
glasgow, renfrewshire PA4 9 RR
UK   PA4 9RR
Manufacturer Contact
jason whittle
newmains avenue
inchinnan business park
glasgow, renfrewshire PA4 9-RR
UK   PA4 9RR
MDR Report Key18693353
MDR Text Key335979580
Report Number9612515-2024-00007
Device Sequence Number1
Product Code DSY
UDI-Device Identifier05037881105130
UDI-Public05037881105130
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K952293
Number of Events Reported1
Summary Report (Y/N)Y
Report Source Manufacturer
Source Type Foreign,Health Professional
Reporter Occupation Physician
Remedial Action Replace
Type of Report Initial,Followup
Report Date 03/14/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/13/2024
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberGELWEAVE STRAIGHT
Device Catalogue Number733008
Device Lot Number25323896
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer02/09/2024
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/19/2024
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured06/07/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age83 YR
Patient SexPrefer Not To Disclose
-
-